jueves, 21 de septiembre de 2023

To List or Not to List; That is the Question – The FTC Signals the Potential for Greater Scrutiny of Patent Information Submissions to FDA September 19, 2023 By Sara W. Koblitz & Kurt R. Karst —

https://www.thefdalawblog.com/2023/09/to-list-or-not-to-list-that-is-the-question-the-ftc-signals-the-potential-for-greater-scrutiny-of-patent-information-submissions-to-fda/?utm_source=rss&utm_medium=rss&utm_campaign=to-list-or-not-to-list-that-is-the-question-the-ftc-signals-the-potential-for-greater-scrutiny-of-patent-information-submissions-to-fda

No hay comentarios: